Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
Clinical trial NCT03444038 · COMPLETED
Trial details
- NCT number
- NCT03444038
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2019-07-12
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.